Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandi N Sheth

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
JMIR Research Protocols|June 15, 2019
Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155)Jessica M Sales, Cam Escoffery, Sophia A Hussen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB TrialIghovwerha Ofotokun, Lauren F Collins, Kehmia Titanji, et al.
Obstetrics and Gynecology|November 26, 2019
Combination Antiretroviral Therapy and Hypertensive Disorders of PregnancyMichele K Saums, Caroline C King, Jenna C Adams, et al.
Open Forum Infectious Diseases|May 21, 2024
Hepatitis C Virus Clearance and Diffusing Capacity for Carbon Monoxide in Women With and Without Human Immunodeficiency VirusAndrew C Curnow, Laurence Huang, Margaret A Fischl, et al.
JMIR Research Protocols|September 25, 2020
Pre-Exposure Prophylaxis Integration Into Family Planning Services at Title X Clinics in the Southeastern United States: Protocol for a Mixed Methods Hybrid Type I Effectiveness Implementation Study (Phase 2 ATN 155)Anandi N Sheth, Sophia A Hussen, Cam Escoffery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2025
Influence of Housing Status on Health Outcomes for Reproductive-Age Women With and Without HIV in the Southern United StatesShreya Ganguly, Olivia Christman, Qian Yang, et al.
HIV Medicine|September 13, 2021
Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohortKartik K Venkatesh, Andrew Edmonds, Daniel Westreich, et al.
Open Forum Infectious Diseases|April 28, 2025
Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United StatesAyako Wendy Fujita, C Christina Mehta, Qian Yang, et al.
Journal of Clinical Pharmacology|April 3, 2014
Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrationsCecile A Delille, Sarah T Pruett, Vincent C Marconi, et al.
Rapid Communications in Mass Spectrometry : RCM|January 10, 2018
Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometryNhi Phung, Karen Kuncze, Hideaki Okochi, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
JMIR Research Protocols|June 15, 2019
Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155)Jessica M Sales, Cam Escoffery, Sophia A Hussen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB TrialIghovwerha Ofotokun, Lauren F Collins, Kehmia Titanji, et al.
Obstetrics and Gynecology|November 26, 2019
Combination Antiretroviral Therapy and Hypertensive Disorders of PregnancyMichele K Saums, Caroline C King, Jenna C Adams, et al.
Open Forum Infectious Diseases|May 21, 2024
Hepatitis C Virus Clearance and Diffusing Capacity for Carbon Monoxide in Women With and Without Human Immunodeficiency VirusAndrew C Curnow, Laurence Huang, Margaret A Fischl, et al.
JMIR Research Protocols|September 25, 2020
Pre-Exposure Prophylaxis Integration Into Family Planning Services at Title X Clinics in the Southeastern United States: Protocol for a Mixed Methods Hybrid Type I Effectiveness Implementation Study (Phase 2 ATN 155)Anandi N Sheth, Sophia A Hussen, Cam Escoffery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2025
Influence of Housing Status on Health Outcomes for Reproductive-Age Women With and Without HIV in the Southern United StatesShreya Ganguly, Olivia Christman, Qian Yang, et al.
HIV Medicine|September 13, 2021
Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohortKartik K Venkatesh, Andrew Edmonds, Daniel Westreich, et al.
Open Forum Infectious Diseases|April 28, 2025
Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United StatesAyako Wendy Fujita, C Christina Mehta, Qian Yang, et al.
Journal of Clinical Pharmacology|April 3, 2014
Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrationsCecile A Delille, Sarah T Pruett, Vincent C Marconi, et al.
Rapid Communications in Mass Spectrometry : RCM|January 10, 2018
Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometryNhi Phung, Karen Kuncze, Hideaki Okochi, et al.
Pageof 15